⌘K

Login Start Free

Home/Filings/4/0000899243-23-016705

4//SEC Filing

BB BIOTECH AG 4

Accession 0000899243-23-016705

CIK 0001701541other

View on SEC.gov Company Profile

Filed

Jun 28, 8:00 PM ET

Accepted

Jun 29, 1:37 PM ET

Size

6.2 KB

Accession

0000899243-23-016705

Insider Transaction Report

Form 4

Period: 2023-06-27

Black Diamond Therapeutics, Inc.BDTX

10% Owner

Transactions

Purchase
Common Stock
2023-06-27$5.49/sh+1,740,000$9,555,036→ 7,117,839 total

BIOTECH GROWTH N V

10% Owner

Transactions

Purchase
Common Stock
2023-06-27$5.49/sh+1,740,000$9,555,036→ 7,117,839 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Black Diamond Therapeutics, Inc.

CIK 0001701541

Entity typeother

IncorporatedSwitzerland

Related Parties

1

filerCIK 0000924223

Filing Metadata

Form type: 4
Filed: Jun 28, 8:00 PM ET
Accepted: Jun 29, 1:37 PM ET
Size: 6.2 KB

View on SEC.gov